Amgen, Sanofi and Regeneron have been forced to cut the cost of their new cholesterol drugs in negotiations with ... Regeneron's Praluent (alirocumab), which have list prices of $14,000 each.
To prevent these issues, doctors often prescribe statins, which are drugs that help lower cholesterol, especially LDL cholesterol, known as “bad” cholesterol because of its link to heart problems.